文献速递乳腺外科

早期乳腺癌各亚型保乳手术加放疗与乳房切除术的生存结局比较

Outcomes of Breast-Conserving Surgery Plus Radiation vs Mastectomy for All Subtypes of Early-Stage Breast Cancer: Analysis of More Than 200,000 Women.
PubMed 文献 · J Am Coll Surg · 2022-01-01

基于SEER 18个登记处2010-2017年214128例I-II期乳腺癌女性数据,比较保乳手术加放疗(BCT)与乳房切除术(MST)的生存结局。BCT在各分子亚型中均显示优于MST的5年总生存和病因特异性生存,校正人口学和临床因素后MST受者生存风险仍显著更高。

要点

  • 214128例早期乳腺癌中41.6%接受乳房切除术。
  • 各分子亚型中BCT的5年总生存和病因特异性生存均优于MST。
  • 校正因素后MST受者总生存和病因特异性生存风险仍显著高于BCT受者。

核心结论

  • 对于所有亚型的早期乳腺癌女性,BCT比乳房切除术获得更好的生存率。
  • 早期乳腺癌女性中乳房切除术的作用应在未来临床试验中重新评估。

研究设计与样本

  • 基于人群的18个SEER癌症登记处数据,纳入2010-2017年诊断为第一原发I-II期乳腺癌并接受BCT或MST的女性。
  • 采用Kaplan-Meier法估计未校正5年总生存和病因特异性生存,采用单变量和多变量Cox比例回归模型确定手术方式对风险比的影响,并校正人口学和临床变量及分子亚型(luminal A、luminal B、三阴性、HER2富集)。

主要发现

  • 214128例乳腺癌患者中41.6%接受MST。
  • 对于不同亚型,BCT的5年总生存和病因特异性生存均优于MST。
  • 校正人口学和临床因素后,所有亚型中MST受者的总生存和病因特异性生存风险仍统计学显著高于BCT受者。

临床怎么用

  • 原文结论为BCT在所有早期乳腺癌亚型中生存优于乳房切除术,乳房切除术在早期乳腺癌中的作用需在未来临床试验中重新评估。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent large retrospective studies suggest that breast-conserving therapy (BCT) plus radiation yielded better outcomes than mastectomy (MST) for women with early-stage breast cancer (ESBC). Whether this is applicable to the different subtypes is unknown. We hypothesize that BCT yielded better outcomes than MST, regardless of subtypes of ESBC. STUDY DESIGN: Data on women diagnosed with first primary stage I to II breast cancer between 2010 and 2017 who underwent either BCT or MST were from the population-based 18 Surveillance, Epidemiology, and End Results cancer registries. The Kaplan-Meier method was used to estimate unadjusted 5-year overall survival and cause-specific survival. Univariable and multivariable Cox proportional regression models were used to determine the impact of surgical approaches on the hazard ratios adjusted for relevant demographic and clinical variables for molecular subtype (luminal A, luminal B, triple-negative, and HER2 enriched). RESULTS: Of the 214,128 patients with breast cancer, 41.6% received MST. For the different subtypes, BCT yielded better 5-year overall survival and cause-specific survival than MST. After adjusting for demographic and clinical factors, the risk of overall survival and cause-specific survival was still statistically significantly higher among MST recipients than BCT recipients for all subtypes. CONCLUSIONS: BCT yielded better survival rates than mastectomy for women with all subtypes of ESBC. The role of mastectomy for women with ESBC should be reassessed in future clinical trials.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Chu QD, Hsieh MC, Yi Y, et al. Outcomes of Breast-Conserving Surgery Plus Radiation vs Mastectomy for All Subtypes of Early-Stage Breast Cancer: Analysis of More Than 200,000 Women. J Am Coll Surg. 2022. PMID: 35290264. doi:10.1097/XCS.0000000000000100

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。